ALCL encompasses a spectrum of mature T-cell malignancies sharing certain features such as anaplastic cytology, strong CD30 expression, and variable loss of T-cell markers, but displaying different clinical presentations, molecular features, and oncogenic mechanisms. The gene discussed is TNFRSF8; the disease is anaplastic large cell lymphoma.